IS5675A - Homogeneous formulations of abacavir, lamivudine and zidovudine - Google Patents
Homogeneous formulations of abacavir, lamivudine and zidovudineInfo
- Publication number
- IS5675A IS5675A IS5675A IS5675A IS5675A IS 5675 A IS5675 A IS 5675A IS 5675 A IS5675 A IS 5675A IS 5675 A IS5675 A IS 5675A IS 5675 A IS5675 A IS 5675A
- Authority
- IS
- Iceland
- Prior art keywords
- abacavir
- lamivudine
- zidovudine
- homogeneous formulations
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809213.3A GB9809213D0 (en) | 1998-04-29 | 1998-04-29 | Pharmaceutical compositions |
| PCT/EP1999/002794 WO1999055372A1 (en) | 1998-04-29 | 1999-04-26 | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5675A true IS5675A (en) | 2000-10-20 |
Family
ID=10831228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5675A IS5675A (en) | 1998-04-29 | 2000-10-20 | Homogeneous formulations of abacavir, lamivudine and zidovudine |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1083932A1 (en) |
| JP (1) | JP2002512979A (en) |
| KR (1) | KR20010043128A (en) |
| CN (1) | CN1411380A (en) |
| AP (1) | AP2000001971A0 (en) |
| AU (1) | AU4135599A (en) |
| BR (1) | BR9910071A (en) |
| CA (1) | CA2330391A1 (en) |
| EA (1) | EA200000997A1 (en) |
| EE (1) | EE200000646A (en) |
| GB (1) | GB9809213D0 (en) |
| HR (1) | HRP20000732A2 (en) |
| HU (1) | HUP0101622A3 (en) |
| ID (1) | ID26955A (en) |
| IL (1) | IL139181A0 (en) |
| IS (1) | IS5675A (en) |
| NO (1) | NO20005418L (en) |
| NZ (1) | NZ507745A (en) |
| PL (1) | PL343710A1 (en) |
| SK (1) | SK16212000A3 (en) |
| TR (1) | TR200003157T2 (en) |
| WO (1) | WO1999055372A1 (en) |
| ZA (1) | ZA200005922B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| CA2374198A1 (en) * | 1998-05-29 | 1999-12-02 | Maki Arai | Combination therapy for treatment of fiv infection |
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| WO2003090762A1 (en) * | 2002-04-23 | 2003-11-06 | Lupin Limited | Long acting compositions comprising zidovudine and lamivudine |
| TW200403061A (en) * | 2002-06-04 | 2004-03-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| CN100335125C (en) * | 2003-06-03 | 2007-09-05 | 上海现代药物制剂工程研究中心 | Interferon nasal spray powder with long service for detoxication and anti-bacteria |
| WO2006114709A1 (en) * | 2005-04-25 | 2006-11-02 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| WO2007013047A2 (en) * | 2005-07-29 | 2007-02-01 | Ranbaxy Laboratories Limited | Water-dispersible anti-retroviral pharmaceutical compositions |
| ES2279707B1 (en) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | ORAL FORMULATIONS THAT INCLUDE 3'-AZIDONUCLEOSIDS. |
| CN101878032A (en) * | 2007-10-02 | 2010-11-03 | 埃默里大学 | Potent combinations of zidovudine and drugs that select for the K65R mutation in the HIV polymerase |
| WO2009092002A1 (en) * | 2008-01-17 | 2009-07-23 | Duquesne University Of The Holy Spirit | Antiretroviral drug formulations for treatment of children exposed to hiv/aids |
| MX356891B (en) | 2010-01-27 | 2018-06-19 | Viiv Healthcare Co | Antiviral therapy. |
| EP2579892A2 (en) | 2010-06-09 | 2013-04-17 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment |
| US20150104511A1 (en) | 2012-03-05 | 2015-04-16 | Cipla Limited | Pharmaceutical Antiretroviral Combinations Comprising Lamivudine, Festinavir and Nevirapine |
| KR20150084772A (en) | 2012-10-23 | 2015-07-22 | 시플라 리미티드 | Pharmaceutical antiretroviral composition |
| NZ753904A (en) * | 2013-06-13 | 2020-07-31 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
-
1999
- 1999-04-26 EE EEP200000646A patent/EE200000646A/en unknown
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 IL IL13918199A patent/IL139181A0/en unknown
- 1999-04-26 CN CN99807983A patent/CN1411380A/en active Pending
- 1999-04-26 EA EA200000997A patent/EA200000997A1/en unknown
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/en not_active IP Right Cessation
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/en unknown
- 1999-04-26 PL PL99343710A patent/PL343710A1/en unknown
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/en not_active Application Discontinuation
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/en active Pending
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/en unknown
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/en unknown
- 1999-04-26 ID IDW20002479A patent/ID26955A/en unknown
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Application Discontinuation
-
2000
- 2000-10-20 IS IS5675A patent/IS5675A/en unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/en unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/en not_active Application Discontinuation
- 2000-10-27 HR HR20000732A patent/HRP20000732A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TR200003157T2 (en) | 2001-01-22 |
| CA2330391A1 (en) | 1999-11-04 |
| IL139181A0 (en) | 2001-11-25 |
| ZA200005922B (en) | 2001-10-23 |
| BR9910071A (en) | 2000-12-26 |
| KR20010043128A (en) | 2001-05-25 |
| GB9809213D0 (en) | 1998-07-01 |
| ID26955A (en) | 2001-02-22 |
| NO20005418D0 (en) | 2000-10-27 |
| AP2000001971A0 (en) | 2000-12-31 |
| EE200000646A (en) | 2002-04-15 |
| HUP0101622A2 (en) | 2002-03-28 |
| HRP20000732A2 (en) | 2001-02-28 |
| NO20005418L (en) | 2000-11-29 |
| JP2002512979A (en) | 2002-05-08 |
| AU4135599A (en) | 1999-11-16 |
| EP1083932A1 (en) | 2001-03-21 |
| PL343710A1 (en) | 2001-08-27 |
| EA200000997A1 (en) | 2001-06-25 |
| CN1411380A (en) | 2003-04-16 |
| WO1999055372A1 (en) | 1999-11-04 |
| HUP0101622A3 (en) | 2003-09-29 |
| SK16212000A3 (en) | 2001-07-10 |
| NZ507745A (en) | 2004-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS5675A (en) | Homogeneous formulations of abacavir, lamivudine and zidovudine | |
| NO20006520D0 (en) | adenosine | |
| DE59910409D1 (en) | distraction | |
| IS5555A (en) | Selekoxib formulations | |
| ID23546A (en) | ZIPRASIDON FORMULATIONS | |
| NO20004240D0 (en) | formulations | |
| ATE224703T1 (en) | EFFORTABLE FORMULATIONS | |
| DK1130966T4 (en) | Antiparasitic formulations | |
| PT1139761E (en) | HERBICID AND CONCENTRATED COMPOSITIONS | |
| DE69908455D1 (en) | inserter | |
| DE69911530D1 (en) | Curable silicone composition | |
| NO20004160D0 (en) | Cross country or cross country skiing | |
| DE69936800D1 (en) | mass spectrometry | |
| NO981187L (en) | Slagm ° lle | |
| IS5024A (en) | Pharmaceutical formulations containing lamivudine and zidovudine | |
| NO20011358D0 (en) | Antiviral combinations | |
| FR2804041B1 (en) | BUBBLE-BLOWING TOY STRUCTURE | |
| DE29814273U1 (en) | Sports shirt | |
| ATE269074T1 (en) | DORAMECTIN FORMULATIONS | |
| DE69920604D1 (en) | Fluorinated blowing agent compositions | |
| ID26655A (en) | MAKING STREPTOKOKUS | |
| DE29813463U1 (en) | ball | |
| DE59902656D1 (en) | PLAYER | |
| ITFI980052A0 (en) | ANTI-RETENTION SPORTS UNIFORM | |
| DE29817687U1 (en) | Envelope |